nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—ALB—lung cancer	0.353	1	CbGaD
Auranofin—ALB—Gefitinib—lung cancer	0.0913	0.415	CbGbCtD
Auranofin—ALB—Erlotinib—lung cancer	0.054	0.246	CbGbCtD
Auranofin—ALB—Irinotecan—lung cancer	0.0487	0.222	CbGbCtD
Auranofin—ALB—Methotrexate—lung cancer	0.0258	0.117	CbGbCtD
Auranofin—PRDX5—respiratory system—lung cancer	0.00698	0.128	CbGeAlD
Auranofin—PRDX5—epithelium—lung cancer	0.00583	0.107	CbGeAlD
Auranofin—PRDX5—bronchus—lung cancer	0.00574	0.105	CbGeAlD
Auranofin—PRDX5—trachea—lung cancer	0.00516	0.0944	CbGeAlD
Auranofin—PRDX5—cardiac atrium—lung cancer	0.00484	0.0887	CbGeAlD
Auranofin—IKBKB—respiratory system—lung cancer	0.00413	0.0757	CbGeAlD
Auranofin—PRDX5—bone marrow—lung cancer	0.00409	0.0749	CbGeAlD
Auranofin—PRDX5—lung—lung cancer	0.0037	0.0679	CbGeAlD
Auranofin—ALB—mammary gland—lung cancer	0.00362	0.0663	CbGeAlD
Auranofin—IKBKB—bronchus—lung cancer	0.0034	0.0623	CbGeAlD
Auranofin—PRDX5—lymph node—lung cancer	0.00253	0.0464	CbGeAlD
Auranofin—IKBKB—lung—lung cancer	0.00219	0.0402	CbGeAlD
Auranofin—IKBKB—lymph node—lung cancer	0.0015	0.0275	CbGeAlD
Auranofin—ALB—lymph node—lung cancer	0.000876	0.016	CbGeAlD
Auranofin—Anorexia—Vinblastine—lung cancer	0.000399	0.00203	CcSEcCtD
Auranofin—Pancytopenia—Etoposide—lung cancer	0.000398	0.00203	CcSEcCtD
Auranofin—Thrombocytopenia—Topotecan—lung cancer	0.000398	0.00203	CcSEcCtD
Auranofin—Stomatitis—Cisplatin—lung cancer	0.000398	0.00203	CcSEcCtD
Auranofin—Conjunctivitis—Cisplatin—lung cancer	0.000397	0.00202	CcSEcCtD
Auranofin—Anaemia—Vinorelbine—lung cancer	0.000393	0.00201	CcSEcCtD
Auranofin—Thrombocytopenia—Erlotinib—lung cancer	0.000393	0.00201	CcSEcCtD
Auranofin—Neutropenia—Etoposide—lung cancer	0.000392	0.002	CcSEcCtD
Auranofin—Melaena—Methotrexate—lung cancer	0.000391	0.00199	CcSEcCtD
Auranofin—Pancytopenia—Paclitaxel—lung cancer	0.00039	0.00199	CcSEcCtD
Auranofin—Angioedema—Vinorelbine—lung cancer	0.000389	0.00198	CcSEcCtD
Auranofin—Visual impairment—Irinotecan—lung cancer	0.000389	0.00198	CcSEcCtD
Auranofin—Pruritus—Teniposide—lung cancer	0.000388	0.00198	CcSEcCtD
Auranofin—Anorexia—Topotecan—lung cancer	0.000387	0.00197	CcSEcCtD
Auranofin—Neutropenia—Paclitaxel—lung cancer	0.000384	0.00196	CcSEcCtD
Auranofin—Anorexia—Erlotinib—lung cancer	0.000383	0.00195	CcSEcCtD
Auranofin—Leukopenia—Vinorelbine—lung cancer	0.000381	0.00194	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—lung cancer	0.000376	0.00192	CcSEcCtD
Auranofin—Aplastic anaemia—Methotrexate—lung cancer	0.000376	0.00192	CcSEcCtD
Auranofin—Diarrhoea—Teniposide—lung cancer	0.000375	0.00191	CcSEcCtD
Auranofin—Weight decreased—Paclitaxel—lung cancer	0.000372	0.0019	CcSEcCtD
Auranofin—Neuropathy peripheral—Etoposide—lung cancer	0.000366	0.00187	CcSEcCtD
Auranofin—Jaundice—Etoposide—lung cancer	0.000364	0.00186	CcSEcCtD
Auranofin—Stomatitis—Etoposide—lung cancer	0.000364	0.00186	CcSEcCtD
Auranofin—Decreased appetite—Vinblastine—lung cancer	0.000363	0.00185	CcSEcCtD
Auranofin—Neuropathy peripheral—Paclitaxel—lung cancer	0.000359	0.00183	CcSEcCtD
Auranofin—Constipation—Vinblastine—lung cancer	0.000358	0.00182	CcSEcCtD
Auranofin—Dyspepsia—Topotecan—lung cancer	0.000358	0.00182	CcSEcCtD
Auranofin—Stomatitis—Paclitaxel—lung cancer	0.000357	0.00182	CcSEcCtD
Auranofin—Alopecia—Irinotecan—lung cancer	0.000356	0.00182	CcSEcCtD
Auranofin—Conjunctivitis—Paclitaxel—lung cancer	0.000356	0.00182	CcSEcCtD
Auranofin—Dyspepsia—Erlotinib—lung cancer	0.000354	0.0018	CcSEcCtD
Auranofin—Decreased appetite—Topotecan—lung cancer	0.000353	0.0018	CcSEcCtD
Auranofin—Visual impairment—Cisplatin—lung cancer	0.000353	0.0018	CcSEcCtD
Auranofin—Haematuria—Paclitaxel—lung cancer	0.000349	0.00178	CcSEcCtD
Auranofin—Decreased appetite—Erlotinib—lung cancer	0.000349	0.00178	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—lung cancer	0.000349	0.00178	CcSEcCtD
Auranofin—Vomiting—Teniposide—lung cancer	0.000348	0.00178	CcSEcCtD
Auranofin—Dysphagia—Docetaxel—lung cancer	0.000348	0.00178	CcSEcCtD
Auranofin—Constipation—Topotecan—lung cancer	0.000347	0.00177	CcSEcCtD
Auranofin—Alopecia—Gemcitabine—lung cancer	0.000347	0.00177	CcSEcCtD
Auranofin—Flatulence—Irinotecan—lung cancer	0.000346	0.00176	CcSEcCtD
Auranofin—Rash—Teniposide—lung cancer	0.000346	0.00176	CcSEcCtD
Auranofin—Dermatitis—Teniposide—lung cancer	0.000345	0.00176	CcSEcCtD
Auranofin—Constipation—Erlotinib—lung cancer	0.000344	0.00175	CcSEcCtD
Auranofin—Eye disorder—Cisplatin—lung cancer	0.000342	0.00175	CcSEcCtD
Auranofin—Gastrointestinal pain—Vinblastine—lung cancer	0.000342	0.00174	CcSEcCtD
Auranofin—Thrombocytopenia—Vinorelbine—lung cancer	0.00034	0.00173	CcSEcCtD
Auranofin—Melaena—Doxorubicin—lung cancer	0.000338	0.00173	CcSEcCtD
Auranofin—Gastrointestinal pain—Topotecan—lung cancer	0.000332	0.00169	CcSEcCtD
Auranofin—Anorexia—Vinorelbine—lung cancer	0.000331	0.00169	CcSEcCtD
Auranofin—Pancytopenia—Docetaxel—lung cancer	0.000331	0.00169	CcSEcCtD
Auranofin—Abdominal pain—Vinblastine—lung cancer	0.000331	0.00169	CcSEcCtD
Auranofin—Gastrointestinal pain—Erlotinib—lung cancer	0.000329	0.00168	CcSEcCtD
Auranofin—Neutropenia—Docetaxel—lung cancer	0.000326	0.00166	CcSEcCtD
Auranofin—Nausea—Teniposide—lung cancer	0.000326	0.00166	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—lung cancer	0.000325	0.00166	CcSEcCtD
Auranofin—Anaemia—Irinotecan—lung cancer	0.000325	0.00165	CcSEcCtD
Auranofin—Alopecia—Cisplatin—lung cancer	0.000324	0.00165	CcSEcCtD
Auranofin—Urticaria—Topotecan—lung cancer	0.000323	0.00165	CcSEcCtD
Auranofin—Abdominal pain—Topotecan—lung cancer	0.000321	0.00164	CcSEcCtD
Auranofin—Abdominal pain—Erlotinib—lung cancer	0.000318	0.00162	CcSEcCtD
Auranofin—Visual impairment—Paclitaxel—lung cancer	0.000317	0.00162	CcSEcCtD
Auranofin—Anaemia—Gemcitabine—lung cancer	0.000316	0.00161	CcSEcCtD
Auranofin—Weight decreased—Docetaxel—lung cancer	0.000315	0.00161	CcSEcCtD
Auranofin—Leukopenia—Irinotecan—lung cancer	0.000314	0.0016	CcSEcCtD
Auranofin—Flatulence—Cisplatin—lung cancer	0.000314	0.0016	CcSEcCtD
Auranofin—Eye disorder—Etoposide—lung cancer	0.000314	0.0016	CcSEcCtD
Auranofin—Dermatitis exfoliative—Methotrexate—lung cancer	0.000308	0.00157	CcSEcCtD
Auranofin—Eye disorder—Paclitaxel—lung cancer	0.000307	0.00157	CcSEcCtD
Auranofin—Leukopenia—Gemcitabine—lung cancer	0.000306	0.00156	CcSEcCtD
Auranofin—Neuropathy peripheral—Docetaxel—lung cancer	0.000304	0.00155	CcSEcCtD
Auranofin—Stomatitis—Docetaxel—lung cancer	0.000303	0.00154	CcSEcCtD
Auranofin—Jaundice—Docetaxel—lung cancer	0.000303	0.00154	CcSEcCtD
Auranofin—Decreased appetite—Vinorelbine—lung cancer	0.000302	0.00154	CcSEcCtD
Auranofin—Conjunctivitis—Docetaxel—lung cancer	0.000302	0.00154	CcSEcCtD
Auranofin—Constipation—Vinorelbine—lung cancer	0.000297	0.00152	CcSEcCtD
Auranofin—Alopecia—Etoposide—lung cancer	0.000296	0.00151	CcSEcCtD
Auranofin—Anaemia—Cisplatin—lung cancer	0.000295	0.0015	CcSEcCtD
Auranofin—Alopecia—Paclitaxel—lung cancer	0.000291	0.00148	CcSEcCtD
Auranofin—Agranulocytosis—Docetaxel—lung cancer	0.00029	0.00148	CcSEcCtD
Auranofin—Pruritus—Topotecan—lung cancer	0.000287	0.00147	CcSEcCtD
Auranofin—Diarrhoea—Vinblastine—lung cancer	0.000286	0.00146	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—lung cancer	0.000286	0.00146	CcSEcCtD
Auranofin—Leukopenia—Cisplatin—lung cancer	0.000285	0.00146	CcSEcCtD
Auranofin—Pruritus—Erlotinib—lung cancer	0.000284	0.00145	CcSEcCtD
Auranofin—Gastrointestinal pain—Vinorelbine—lung cancer	0.000284	0.00145	CcSEcCtD
Auranofin—Flatulence—Paclitaxel—lung cancer	0.000282	0.00144	CcSEcCtD
Auranofin—Thrombocytopenia—Irinotecan—lung cancer	0.000281	0.00143	CcSEcCtD
Auranofin—Dysgeusia—Paclitaxel—lung cancer	0.00028	0.00143	CcSEcCtD
Auranofin—Diarrhoea—Topotecan—lung cancer	0.000278	0.00142	CcSEcCtD
Auranofin—Urticaria—Vinorelbine—lung cancer	0.000276	0.00141	CcSEcCtD
Auranofin—Diarrhoea—Erlotinib—lung cancer	0.000275	0.0014	CcSEcCtD
Auranofin—Abdominal pain—Vinorelbine—lung cancer	0.000275	0.0014	CcSEcCtD
Auranofin—Thrombocytopenia—Gemcitabine—lung cancer	0.000273	0.00139	CcSEcCtD
Auranofin—Anorexia—Irinotecan—lung cancer	0.000273	0.00139	CcSEcCtD
Auranofin—Anaemia—Etoposide—lung cancer	0.00027	0.00138	CcSEcCtD
Auranofin—Visual impairment—Docetaxel—lung cancer	0.000269	0.00137	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000267	0.00136	CcSEcCtD
Auranofin—Anorexia—Gemcitabine—lung cancer	0.000266	0.00136	CcSEcCtD
Auranofin—Vomiting—Vinblastine—lung cancer	0.000266	0.00136	CcSEcCtD
Auranofin—Anaemia—Paclitaxel—lung cancer	0.000265	0.00135	CcSEcCtD
Auranofin—Angioedema—Paclitaxel—lung cancer	0.000262	0.00133	CcSEcCtD
Auranofin—Leukopenia—Etoposide—lung cancer	0.000261	0.00133	CcSEcCtD
Auranofin—Eye disorder—Docetaxel—lung cancer	0.000261	0.00133	CcSEcCtD
Auranofin—Vomiting—Topotecan—lung cancer	0.000258	0.00132	CcSEcCtD
Auranofin—Leukopenia—Paclitaxel—lung cancer	0.000256	0.00131	CcSEcCtD
Auranofin—Rash—Topotecan—lung cancer	0.000256	0.00131	CcSEcCtD
Auranofin—Dermatitis—Topotecan—lung cancer	0.000256	0.0013	CcSEcCtD
Auranofin—Vomiting—Erlotinib—lung cancer	0.000256	0.0013	CcSEcCtD
Auranofin—Thrombocytopenia—Cisplatin—lung cancer	0.000255	0.0013	CcSEcCtD
Auranofin—Rash—Erlotinib—lung cancer	0.000253	0.00129	CcSEcCtD
Auranofin—Dermatitis—Erlotinib—lung cancer	0.000253	0.00129	CcSEcCtD
Auranofin—Dyspepsia—Irinotecan—lung cancer	0.000252	0.00129	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000252	0.00128	CcSEcCtD
Auranofin—Decreased appetite—Irinotecan—lung cancer	0.000249	0.00127	CcSEcCtD
Auranofin—Eosinophilia—Methotrexate—lung cancer	0.000249	0.00127	CcSEcCtD
Auranofin—Nausea—Vinblastine—lung cancer	0.000248	0.00127	CcSEcCtD
Auranofin—Anorexia—Cisplatin—lung cancer	0.000248	0.00126	CcSEcCtD
Auranofin—Alopecia—Docetaxel—lung cancer	0.000246	0.00126	CcSEcCtD
Auranofin—Pruritus—Vinorelbine—lung cancer	0.000246	0.00125	CcSEcCtD
Auranofin—Constipation—Irinotecan—lung cancer	0.000245	0.00125	CcSEcCtD
Auranofin—Decreased appetite—Gemcitabine—lung cancer	0.000243	0.00124	CcSEcCtD
Auranofin—Nausea—Topotecan—lung cancer	0.000241	0.00123	CcSEcCtD
Auranofin—Constipation—Gemcitabine—lung cancer	0.000239	0.00122	CcSEcCtD
Auranofin—Nausea—Erlotinib—lung cancer	0.000239	0.00122	CcSEcCtD
Auranofin—Pancytopenia—Methotrexate—lung cancer	0.000238	0.00122	CcSEcCtD
Auranofin—Diarrhoea—Vinorelbine—lung cancer	0.000238	0.00121	CcSEcCtD
Auranofin—Dysgeusia—Docetaxel—lung cancer	0.000238	0.00121	CcSEcCtD
Auranofin—Neutropenia—Methotrexate—lung cancer	0.000235	0.0012	CcSEcCtD
Auranofin—Gastrointestinal pain—Irinotecan—lung cancer	0.000234	0.00119	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—lung cancer	0.000233	0.00119	CcSEcCtD
Auranofin—Thrombocytopenia—Paclitaxel—lung cancer	0.000229	0.00117	CcSEcCtD
Auranofin—Anorexia—Etoposide—lung cancer	0.000227	0.00116	CcSEcCtD
Auranofin—Abdominal pain—Irinotecan—lung cancer	0.000227	0.00116	CcSEcCtD
Auranofin—Decreased appetite—Cisplatin—lung cancer	0.000226	0.00115	CcSEcCtD
Auranofin—Anaemia—Docetaxel—lung cancer	0.000224	0.00114	CcSEcCtD
Auranofin—Anorexia—Paclitaxel—lung cancer	0.000223	0.00114	CcSEcCtD
Auranofin—Vomiting—Vinorelbine—lung cancer	0.000221	0.00113	CcSEcCtD
Auranofin—Rash—Vinorelbine—lung cancer	0.000219	0.00112	CcSEcCtD
Auranofin—Dermatitis—Vinorelbine—lung cancer	0.000219	0.00112	CcSEcCtD
Auranofin—Stomatitis—Methotrexate—lung cancer	0.000218	0.00111	CcSEcCtD
Auranofin—Conjunctivitis—Methotrexate—lung cancer	0.000218	0.00111	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—lung cancer	0.000217	0.00111	CcSEcCtD
Auranofin—Leukopenia—Docetaxel—lung cancer	0.000217	0.00111	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—lung cancer	0.000215	0.0011	CcSEcCtD
Auranofin—Haematuria—Methotrexate—lung cancer	0.000213	0.00109	CcSEcCtD
Auranofin—Agranulocytosis—Methotrexate—lung cancer	0.000209	0.00107	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—lung cancer	0.000207	0.00106	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—lung cancer	0.000206	0.00105	CcSEcCtD
Auranofin—Nausea—Vinorelbine—lung cancer	0.000206	0.00105	CcSEcCtD
Auranofin—Dyspepsia—Paclitaxel—lung cancer	0.000206	0.00105	CcSEcCtD
Auranofin—Constipation—Etoposide—lung cancer	0.000204	0.00104	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—lung cancer	0.000203	0.00104	CcSEcCtD
Auranofin—Decreased appetite—Paclitaxel—lung cancer	0.000203	0.00104	CcSEcCtD
Auranofin—Constipation—Paclitaxel—lung cancer	0.0002	0.00102	CcSEcCtD
Auranofin—Pruritus—Gemcitabine—lung cancer	0.000197	0.00101	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—lung cancer	0.000197	0.001	CcSEcCtD
Auranofin—Diarrhoea—Irinotecan—lung cancer	0.000196	0.001	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—lung cancer	0.000195	0.000994	CcSEcCtD
Auranofin—Thrombocytopenia—Docetaxel—lung cancer	0.000194	0.000989	CcSEcCtD
Auranofin—Visual impairment—Methotrexate—lung cancer	0.000194	0.000988	CcSEcCtD
Auranofin—Gastrointestinal pain—Paclitaxel—lung cancer	0.000191	0.000974	CcSEcCtD
Auranofin—Diarrhoea—Gemcitabine—lung cancer	0.000191	0.000974	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—lung cancer	0.00019	0.000969	CcSEcCtD
Auranofin—Urticaria—Etoposide—lung cancer	0.000189	0.000966	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—lung cancer	0.000189	0.000963	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—lung cancer	0.000189	0.000963	CcSEcCtD
Auranofin—Anorexia—Docetaxel—lung cancer	0.000189	0.000963	CcSEcCtD
Auranofin—Abdominal pain—Etoposide—lung cancer	0.000188	0.000961	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—lung cancer	0.000188	0.000961	CcSEcCtD
Auranofin—Eye disorder—Methotrexate—lung cancer	0.000188	0.000958	CcSEcCtD
Auranofin—Urticaria—Paclitaxel—lung cancer	0.000186	0.000947	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—lung cancer	0.000185	0.000942	CcSEcCtD
Auranofin—Abdominal pain—Paclitaxel—lung cancer	0.000185	0.000942	CcSEcCtD
Auranofin—Vomiting—Irinotecan—lung cancer	0.000182	0.000929	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—lung cancer	0.000181	0.000922	CcSEcCtD
Auranofin—Rash—Irinotecan—lung cancer	0.000181	0.000921	CcSEcCtD
Auranofin—Dermatitis—Irinotecan—lung cancer	0.000181	0.00092	CcSEcCtD
Auranofin—Diarrhoea—Cisplatin—lung cancer	0.000178	0.000908	CcSEcCtD
Auranofin—Alopecia—Methotrexate—lung cancer	0.000178	0.000906	CcSEcCtD
Auranofin—Vomiting—Gemcitabine—lung cancer	0.000177	0.000905	CcSEcCtD
Auranofin—Rash—Gemcitabine—lung cancer	0.000176	0.000897	CcSEcCtD
Auranofin—Dermatitis—Gemcitabine—lung cancer	0.000176	0.000897	CcSEcCtD
Auranofin—Dyspepsia—Docetaxel—lung cancer	0.000174	0.000889	CcSEcCtD
Auranofin—Decreased appetite—Docetaxel—lung cancer	0.000172	0.000878	CcSEcCtD
Auranofin—Dysgeusia—Methotrexate—lung cancer	0.000171	0.000874	CcSEcCtD
Auranofin—Nausea—Irinotecan—lung cancer	0.00017	0.000868	CcSEcCtD
Auranofin—Constipation—Docetaxel—lung cancer	0.000169	0.000864	CcSEcCtD
Auranofin—Pruritus—Etoposide—lung cancer	0.000169	0.00086	CcSEcCtD
Auranofin—Visual impairment—Doxorubicin—lung cancer	0.000168	0.000855	CcSEcCtD
Auranofin—Nausea—Gemcitabine—lung cancer	0.000166	0.000845	CcSEcCtD
Auranofin—Vomiting—Cisplatin—lung cancer	0.000165	0.000844	CcSEcCtD
Auranofin—Pruritus—Paclitaxel—lung cancer	0.000165	0.000843	CcSEcCtD
Auranofin—Rash—Cisplatin—lung cancer	0.000164	0.000837	CcSEcCtD
Auranofin—Dermatitis—Cisplatin—lung cancer	0.000164	0.000836	CcSEcCtD
Auranofin—Diarrhoea—Etoposide—lung cancer	0.000163	0.000832	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—lung cancer	0.000163	0.000829	CcSEcCtD
Auranofin—Gastrointestinal pain—Docetaxel—lung cancer	0.000162	0.000826	CcSEcCtD
Auranofin—Anaemia—Methotrexate—lung cancer	0.000162	0.000824	CcSEcCtD
Auranofin—Diarrhoea—Paclitaxel—lung cancer	0.00016	0.000815	CcSEcCtD
Auranofin—Abdominal pain—Docetaxel—lung cancer	0.000157	0.000799	CcSEcCtD
Auranofin—Leukopenia—Methotrexate—lung cancer	0.000157	0.000798	CcSEcCtD
Auranofin—Nausea—Cisplatin—lung cancer	0.000155	0.000788	CcSEcCtD
Auranofin—Alopecia—Doxorubicin—lung cancer	0.000154	0.000784	CcSEcCtD
Auranofin—Vomiting—Etoposide—lung cancer	0.000152	0.000773	CcSEcCtD
Auranofin—Rash—Etoposide—lung cancer	0.00015	0.000766	CcSEcCtD
Auranofin—Dermatitis—Etoposide—lung cancer	0.00015	0.000766	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—lung cancer	0.000149	0.000761	CcSEcCtD
Auranofin—Vomiting—Paclitaxel—lung cancer	0.000149	0.000758	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—lung cancer	0.000148	0.000756	CcSEcCtD
Auranofin—Rash—Paclitaxel—lung cancer	0.000147	0.000751	CcSEcCtD
Auranofin—Dermatitis—Paclitaxel—lung cancer	0.000147	0.000751	CcSEcCtD
Auranofin—Nausea—Etoposide—lung cancer	0.000142	0.000722	CcSEcCtD
Auranofin—Pruritus—Docetaxel—lung cancer	0.00014	0.000715	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—lung cancer	0.00014	0.000714	CcSEcCtD
Auranofin—Thrombocytopenia—Methotrexate—lung cancer	0.00014	0.000713	CcSEcCtD
Auranofin—Nausea—Paclitaxel—lung cancer	0.000139	0.000708	CcSEcCtD
Auranofin—Anorexia—Methotrexate—lung cancer	0.000136	0.000694	CcSEcCtD
Auranofin—Leukopenia—Doxorubicin—lung cancer	0.000136	0.000691	CcSEcCtD
Auranofin—Diarrhoea—Docetaxel—lung cancer	0.000136	0.000691	CcSEcCtD
Auranofin—Vomiting—Docetaxel—lung cancer	0.000126	0.000642	CcSEcCtD
Auranofin—Dyspepsia—Methotrexate—lung cancer	0.000126	0.000641	CcSEcCtD
Auranofin—Rash—Docetaxel—lung cancer	0.000125	0.000637	CcSEcCtD
Auranofin—Dermatitis—Docetaxel—lung cancer	0.000125	0.000636	CcSEcCtD
Auranofin—Decreased appetite—Methotrexate—lung cancer	0.000124	0.000633	CcSEcCtD
Auranofin—Thrombocytopenia—Doxorubicin—lung cancer	0.000121	0.000617	CcSEcCtD
Auranofin—Anorexia—Doxorubicin—lung cancer	0.000118	0.000601	CcSEcCtD
Auranofin—Nausea—Docetaxel—lung cancer	0.000118	0.0006	CcSEcCtD
Auranofin—Gastrointestinal pain—Methotrexate—lung cancer	0.000117	0.000595	CcSEcCtD
Auranofin—Urticaria—Methotrexate—lung cancer	0.000113	0.000578	CcSEcCtD
Auranofin—Abdominal pain—Methotrexate—lung cancer	0.000113	0.000576	CcSEcCtD
Auranofin—Dyspepsia—Doxorubicin—lung cancer	0.000109	0.000555	CcSEcCtD
Auranofin—Decreased appetite—Doxorubicin—lung cancer	0.000107	0.000548	CcSEcCtD
Auranofin—Constipation—Doxorubicin—lung cancer	0.000106	0.000539	CcSEcCtD
Auranofin—Gastrointestinal pain—Doxorubicin—lung cancer	0.000101	0.000515	CcSEcCtD
Auranofin—Pruritus—Methotrexate—lung cancer	0.000101	0.000515	CcSEcCtD
Auranofin—Urticaria—Doxorubicin—lung cancer	9.82e-05	0.000501	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—lung cancer	9.77e-05	0.000498	CcSEcCtD
Auranofin—Diarrhoea—Methotrexate—lung cancer	9.77e-05	0.000498	CcSEcCtD
Auranofin—Vomiting—Methotrexate—lung cancer	9.08e-05	0.000463	CcSEcCtD
Auranofin—Rash—Methotrexate—lung cancer	9e-05	0.000459	CcSEcCtD
Auranofin—Dermatitis—Methotrexate—lung cancer	8.99e-05	0.000459	CcSEcCtD
Auranofin—Pruritus—Doxorubicin—lung cancer	8.75e-05	0.000446	CcSEcCtD
Auranofin—Nausea—Methotrexate—lung cancer	8.48e-05	0.000432	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—lung cancer	8.46e-05	0.000431	CcSEcCtD
Auranofin—Vomiting—Doxorubicin—lung cancer	7.86e-05	0.000401	CcSEcCtD
Auranofin—Rash—Doxorubicin—lung cancer	7.79e-05	0.000397	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—lung cancer	7.79e-05	0.000397	CcSEcCtD
Auranofin—Nausea—Doxorubicin—lung cancer	7.34e-05	0.000374	CcSEcCtD
Auranofin—IKBKB—Innate Immune System—KIT—lung cancer	3.43e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C1—lung cancer	3.42e-05	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—OXTR—lung cancer	3.42e-05	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GRP—lung cancer	3.42e-05	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—MAPK3—lung cancer	3.41e-05	0.000192	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGF—lung cancer	3.39e-05	0.000192	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—IL6—lung cancer	3.38e-05	0.000191	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—lung cancer	3.37e-05	0.00019	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KIT—lung cancer	3.3e-05	0.000186	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGF—lung cancer	3.26e-05	0.000184	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM2—lung cancer	3.25e-05	0.000184	CbGpPWpGaD
Auranofin—ALB—Metabolism—CNDP2—lung cancer	3.25e-05	0.000184	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—EGFR—lung cancer	3.24e-05	0.000183	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CASP8—lung cancer	3.2e-05	0.000181	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—GNG11—lung cancer	3.2e-05	0.000181	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6R—lung cancer	3.19e-05	0.00018	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CREBBP—lung cancer	3.18e-05	0.00018	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTMR3—lung cancer	3.16e-05	0.000179	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—lung cancer	3.12e-05	0.000176	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—lung cancer	3.11e-05	0.000176	CbGpPWpGaD
Auranofin—ALB—Metabolism—PGAM1—lung cancer	3.08e-05	0.000174	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—RAF1—lung cancer	3.07e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—lung cancer	3.06e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FOXO3—lung cancer	3.06e-05	0.000173	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFC—lung cancer	3.04e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAP2K1—lung cancer	3.04e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—lung cancer	3.03e-05	0.000171	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CD—lung cancer	3.02e-05	0.000171	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CB—lung cancer	3e-05	0.000169	CbGpPWpGaD
Auranofin—ALB—Hemostasis—ITGB1—lung cancer	2.97e-05	0.000168	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ITGB1—lung cancer	2.95e-05	0.000166	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2A7—lung cancer	2.94e-05	0.000166	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CD—lung cancer	2.9e-05	0.000164	CbGpPWpGaD
Auranofin—ALB—Metabolism—SDC4—lung cancer	2.88e-05	0.000163	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ADCY1—lung cancer	2.87e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—lung cancer	2.86e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—lung cancer	2.81e-05	0.000159	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PPP2R1B—lung cancer	2.8e-05	0.000158	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMARCA4—lung cancer	2.8e-05	0.000158	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—IL2—lung cancer	2.75e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MDM2—lung cancer	2.7e-05	0.000153	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HSPB1—lung cancer	2.7e-05	0.000153	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—RAF1—lung cancer	2.7e-05	0.000152	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTHLH—lung cancer	2.67e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—lung cancer	2.67e-05	0.000151	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD8A—lung cancer	2.66e-05	0.00015	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—lung cancer	2.65e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CB—lung cancer	2.63e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MTOR—lung cancer	2.63e-05	0.000149	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CD4—lung cancer	2.63e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Metabolism—RRM1—lung cancer	2.62e-05	0.000148	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA3—lung cancer	2.62e-05	0.000148	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—lung cancer	2.6e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MDM2—lung cancer	2.6e-05	0.000147	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—RAF1—lung cancer	2.59e-05	0.000146	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—lung cancer	2.56e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IL6—lung cancer	2.53e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—MTOR—lung cancer	2.53e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CB—lung cancer	2.53e-05	0.000143	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CD4—lung cancer	2.52e-05	0.000142	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ANXA1—lung cancer	2.51e-05	0.000142	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—AVP—lung cancer	2.5e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—IL6—lung cancer	2.49e-05	0.000141	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB3—lung cancer	2.48e-05	0.00014	CbGpPWpGaD
Auranofin—ALB—Metabolism—B4GALT5—lung cancer	2.46e-05	0.000139	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FLT1—lung cancer	2.43e-05	0.000137	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—ABCB1—lung cancer	2.42e-05	0.000137	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—SRC—lung cancer	2.4e-05	0.000136	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA4—lung cancer	2.4e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APP—lung cancer	2.38e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NOTCH3—lung cancer	2.38e-05	0.000135	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGF9—lung cancer	2.36e-05	0.000133	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—JUN—lung cancer	2.35e-05	0.000133	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.34e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—lung cancer	2.34e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA2—lung cancer	2.34e-05	0.000132	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MMP1—lung cancer	2.31e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR1—lung cancer	2.31e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—lung cancer	2.3e-05	0.00013	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1A—lung cancer	2.28e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Immune System—BCL2L1—lung cancer	2.28e-05	0.000129	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—lung cancer	2.27e-05	0.000128	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUNB—lung cancer	2.26e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTA1—lung cancer	2.25e-05	0.000127	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCC3—lung cancer	2.23e-05	0.000126	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—MAPK3—lung cancer	2.21e-05	0.000125	CbGpPWpGaD
Auranofin—ALB—Hemostasis—APOA1—lung cancer	2.21e-05	0.000125	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1A—lung cancer	2.19e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—lung cancer	2.18e-05	0.000123	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—lung cancer	2.17e-05	0.000122	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C1—lung cancer	2.16e-05	0.000122	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—SRC—lung cancer	2.11e-05	0.000119	CbGpPWpGaD
Auranofin—ALB—Metabolism—UGT1A1—lung cancer	2.1e-05	0.000118	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STK11—lung cancer	2.05e-05	0.000116	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—lung cancer	2.03e-05	0.000115	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SRC—lung cancer	2.02e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Metabolism—GNG11—lung cancer	2.02e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CG—lung cancer	2.02e-05	0.000114	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.01e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KIT—lung cancer	2e-05	0.000113	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EGF—lung cancer	1.99e-05	0.000113	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGF—lung cancer	1.98e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FOXO3—lung cancer	1.98e-05	0.000112	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—lung cancer	1.95e-05	0.00011	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—MAPK3—lung cancer	1.94e-05	0.00011	CbGpPWpGaD
Auranofin—ALB—Metabolism—ALDOA—lung cancer	1.92e-05	0.000109	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—APOA1—lung cancer	1.91e-05	0.000108	CbGpPWpGaD
Auranofin—ALB—Hemostasis—CREBBP—lung cancer	1.87e-05	0.000106	CbGpPWpGaD
Auranofin—ALB—Metabolism—NCOA3—lung cancer	1.87e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CASP8—lung cancer	1.86e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6R—lung cancer	1.86e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CREBBP—lung cancer	1.85e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AVP—lung cancer	1.85e-05	0.000105	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EGFR—lung cancer	1.85e-05	0.000104	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—lung cancer	1.84e-05	0.000104	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.84e-05	0.000104	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—lung cancer	1.83e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCG2—lung cancer	1.82e-05	0.000103	CbGpPWpGaD
Auranofin—ALB—Metabolism—ADCY1—lung cancer	1.82e-05	0.000103	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1R—lung cancer	1.78e-05	0.000101	CbGpPWpGaD
Auranofin—ALB—Metabolism—HPGDS—lung cancer	1.78e-05	0.000101	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO2—lung cancer	1.78e-05	0.000101	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—EGFR—lung cancer	1.77e-05	0.0001	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CD—lung cancer	1.77e-05	0.0001	CbGpPWpGaD
Auranofin—ALB—Metabolism—PPP2R1B—lung cancer	1.77e-05	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAP2K1—lung cancer	1.77e-05	0.0001	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CD—lung cancer	1.76e-05	9.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HES1—lung cancer	1.75e-05	9.89e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.75e-05	9.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—lung cancer	1.75e-05	9.86e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTT1—lung cancer	1.73e-05	9.76e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2A6—lung cancer	1.71e-05	9.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GCLC—lung cancer	1.71e-05	9.65e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.7e-05	9.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—lung cancer	1.68e-05	9.47e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ENO1—lung cancer	1.62e-05	9.15e-05	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—CREBBP—lung cancer	1.62e-05	9.14e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.61e-05	9.11e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—lung cancer	1.6e-05	9.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB3—lung cancer	1.6e-05	9.04e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—RAF1—lung cancer	1.58e-05	8.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MDM2—lung cancer	1.58e-05	8.9e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—RAF1—lung cancer	1.57e-05	8.87e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—lung cancer	1.55e-05	8.77e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CB—lung cancer	1.54e-05	8.72e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—lung cancer	1.54e-05	8.7e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TERT—lung cancer	1.53e-05	8.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MTOR—lung cancer	1.53e-05	8.66e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CB—lung cancer	1.53e-05	8.66e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CD4—lung cancer	1.53e-05	8.64e-05	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—lung cancer	1.49e-05	8.43e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR1—lung cancer	1.49e-05	8.42e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—lung cancer	1.48e-05	8.38e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HIF1A—lung cancer	1.47e-05	8.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP2E1—lung cancer	1.45e-05	8.2e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—NQO1—lung cancer	1.44e-05	8.11e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—lung cancer	1.43e-05	8.05e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—IL6—lung cancer	1.42e-05	8.02e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IL2—lung cancer	1.42e-05	8.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APOA1—lung cancer	1.42e-05	8e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL2—lung cancer	1.41e-05	7.95e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.41e-05	7.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KDR—lung cancer	1.4e-05	7.93e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.39e-05	7.87e-05	CbGpPWpGaD
Auranofin—ALB—Transmembrane transport of small molecules—RAF1—lung cancer	1.37e-05	7.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—JUN—lung cancer	1.37e-05	7.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1A—lung cancer	1.33e-05	7.5e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—lung cancer	1.32e-05	7.48e-05	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—lung cancer	1.31e-05	7.4e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—STK11—lung cancer	1.29e-05	7.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CG—lung cancer	1.29e-05	7.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KIT—lung cancer	1.29e-05	7.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—APC—lung cancer	1.29e-05	7.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGF—lung cancer	1.28e-05	7.22e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—lung cancer	1.27e-05	7.19e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—lung cancer	1.26e-05	7.13e-05	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—lung cancer	1.26e-05	7.11e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—SRC—lung cancer	1.24e-05	6.99e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—POMC—lung cancer	1.23e-05	6.95e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SRC—lung cancer	1.23e-05	6.94e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—BRAF—lung cancer	1.22e-05	6.87e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.22e-05	6.86e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—lung cancer	1.21e-05	6.81e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6R—lung cancer	1.2e-05	6.78e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CREBBP—lung cancer	1.2e-05	6.77e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTP1—lung cancer	1.2e-05	6.77e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—lung cancer	1.19e-05	6.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—STAT3—lung cancer	1.18e-05	6.69e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—lung cancer	1.18e-05	6.67e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CAT—lung cancer	1.17e-05	6.58e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.16e-05	6.55e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAP2K1—lung cancer	1.14e-05	6.46e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—MAPK3—lung cancer	1.14e-05	6.44e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CD—lung cancer	1.14e-05	6.42e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ABCB1—lung cancer	1.13e-05	6.4e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—MAPK3—lung cancer	1.13e-05	6.39e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—TYMS—lung cancer	1.11e-05	6.29e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—GSTM1—lung cancer	1.1e-05	6.22e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EGFR—lung cancer	1.08e-05	6.08e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP1A1—lung cancer	1.04e-05	5.89e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—ERCC2—lung cancer	1.03e-05	5.85e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—lung cancer	1.03e-05	5.79e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MDM2—lung cancer	1.02e-05	5.75e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—lung cancer	1.02e-05	5.74e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RAF1—lung cancer	1.01e-05	5.73e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—lung cancer	1e-05	5.67e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CB—lung cancer	9.91e-06	5.6e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MTOR—lung cancer	9.91e-06	5.6e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—lung cancer	9.52e-06	5.38e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—lung cancer	9.42e-06	5.32e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—lung cancer	9.34e-06	5.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CASP3—lung cancer	9.11e-06	5.15e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—lung cancer	9.11e-06	5.15e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL2—lung cancer	9.1e-06	5.14e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—APOA1—lung cancer	8.95e-06	5.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCND1—lung cancer	8.87e-06	5.01e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—JUN—lung cancer	8.85e-06	5e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—lung cancer	8.71e-06	4.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—lung cancer	8.64e-06	4.88e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MMP9—lung cancer	8.61e-06	4.86e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1A—lung cancer	8.58e-06	4.85e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.57e-06	4.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—lung cancer	8.56e-06	4.84e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IL6—lung cancer	8.27e-06	4.67e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CG—lung cancer	8.17e-06	4.62e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—lung cancer	8.17e-06	4.61e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SRC—lung cancer	7.94e-06	4.48e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—POMC—lung cancer	7.78e-06	4.39e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—lung cancer	7.73e-06	4.37e-05	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—lung cancer	7.69e-06	4.34e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STAT3—lung cancer	7.66e-06	4.33e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—lung cancer	7.64e-06	4.31e-05	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—lung cancer	7.63e-06	4.31e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—CREBBP—lung cancer	7.58e-06	4.28e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MAPK3—lung cancer	7.32e-06	4.13e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CD—lung cancer	7.19e-06	4.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—MYC—lung cancer	7.12e-06	4.02e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EGFR—lung cancer	6.96e-06	3.93e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—lung cancer	6.58e-06	3.71e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CB—lung cancer	6.26e-06	3.54e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTGS2—lung cancer	6.21e-06	3.51e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—lung cancer	6.04e-06	3.41e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—lung cancer	5.84e-06	3.3e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—lung cancer	5.59e-06	3.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—lung cancer	5.41e-06	3.06e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IL6—lung cancer	5.35e-06	3.02e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—lung cancer	5.16e-06	2.92e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—lung cancer	4.93e-06	2.79e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—lung cancer	3.82e-06	2.16e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—lung cancer	3.12e-06	1.76e-05	CbGpPWpGaD
